SCHEMBL197022

SCHEMBL197022

Nc1ccccc1CCCC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.57
HDAC4 P56524 2/20 0.57
HDAC1 Q13547 2/20 0.57
HDAC7 Q8WUI4 2/20 0.57
HDAC2 Q92769 2/20 0.57
HDAC10 Q969S8 2/20 0.57
HDAC11 Q96DB2 2/20 0.57
HDAC8 Q9BY41 2/20 0.57
HDAC6 Q9UBN7 2/20 0.57
HDAC9 Q9UKV0 2/20 0.57
HDAC5 Q9UQL6 2/20 0.57
MAPK1 P28482 1/20 0.57
ADRA1A P35348 1/20 0.57
SLC6A3 Q01959 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
MAPT P10636 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP1A2 P05177 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7434059 0.98 HDAC3 (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4844595 0.94 MAPT (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL28415269 0.93 MAPT (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL28413601 0.93 MAPT (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL28421401 0.93 MAPT (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL503569 0.93 MAPT (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL28417932 0.93 MAPT (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL28421388 0.93 MAPT (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL28421444 0.93 MAPT (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL89295 0.88 KEAP1 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023020531-A1 METHOD FOR SYNTHESIZING 5,8-DIAMINO-3,4-DIHYDRO-2H-1-NAPHTHALENONE AND INTERMEDIATE COMPOUND USED THEREIN 江苏迈威康新药研发有限公司 2023-02-23 WO claimed
CN-115703712-A Process for the synthesis of 5,8-diamino-3,4-dihydro-2H-1-naphthalenone and intermediate compounds useful therein 江苏迈威康新药研发有限公司 2023-02-17 CN claimed
EP-3059004-B1 METHOD FOR REMOVING SOX FROM GAS WITH COMPLEX ALCOHOL-AMINE SOLUTION BEIJING BOYUAN HENGSHENG HIGH TECH CO LTD (CN) 2021-06-30 EP claimed
CN-108276473-A A kind of insect kassinin kinin analog and its application in control of insect 中国农业大学 2018-07-13 CN claimed
US-9999852-B2 Method for removing SOx from gas with compound alcohol-amine solution BEIJING BOYUAN HENGSHENG HIGH-TECHNOLOGY CO., LTD (CN) 2018-06-19 US claimed
CN-106456662-A Compositions of pentosan polysulfate for oral administration and methods of use thereof 奥利金制药公司 2017-02-22 CN claimed
US-20160243491-A1 Method for Removing SOx from Gas with Compound Alcohol-Amine Solution PEKING UNIVERSITY (CN) 2016-08-25 US claimed
EP-3059004-A1 METHOD FOR REMOVING SOX FROM GAS WITHNCOMPOUND ALCOHOL-AMINE SOLUTION Beijing Boyuan-Hengsheng High-Technology Co., Ltd. (CN) 2016-08-24 EP claimed
US-20090220604-A1 AMINO ACIDS IN MICELLE PREPARATION ANGIOTECH INTERNATIONAL AG (CH) 2009-09-03 US claimed
US-7521216-B2 Nitrilases and methods for making and using them VERENIUM CORPORATION (US) 2009-04-21 US claimed
US-20030032774-A1 Novel opioid peptides for the treatment of pain ASTRAZENECA AB 2003-02-13 US claimed
US-5962710-A Method of preparing salicyloylamino acids EMISPHERE TECHNOLOGIES, INC. (US) 1999-10-05 US claimed
EP-0883629-A1 OLIGOPEPTIDES FOR DRUG DELIVERY Emisphere Technologies, Inc. (US) 1998-12-16 EP claimed
WO-1998050341-A1 METHOD OF PREPARING SALICYLOYLAMINO ACIDS EMISPHERE TECHNOLOGIES, INC. (US) 1998-11-12 WO claimed
CN-1039126-C Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds MENARINI FARMA IND (IT) 1998-07-15 CN claimed
CN-1183786-A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition MENARINI FARMA IND (IT) 1998-06-03 CN claimed
WO-1997031938-A9 OLIGOPEPTIDES FOR DRUG DELIVERY 1997-11-20 WO claimed
WO-1997031938-A1 OLIGOPEPTIDES FOR DRUG DELIVERY EMISPHERE TECHNOLOGIES, INC. (US) 1997-09-04 WO claimed
US-5512548-A CHOLESTERYL ESTER TRANSFER PROTEIN SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) 1996-04-30 US claimed
CN-1080916-A The quinic tricyclic compound of anti-column foot, its preparation method and contain the pharmaceutical composition of this compound MENARINI FARMA IND (IT) 1994-01-19 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032774-A1 Novel opioid peptides for the treatment of pain OPRL1, OPRK1, OPRM1 HDAC3 2504/4885HDAC4 4086/4885HDAC1 4180/4885
US-20090220604-A1 AMINO ACIDS IN MICELLE PREPARATION MLX, SLC1A5, BMX HDAC3 4868/4885HDAC4 4803/4885HDAC1 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.